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wt are shown in purple, blue, cyan, green, orange and red at 0, 0.2, 0.6, 1.0, 1.6 and 3.0 equivalents (molar ratio of peptide to protein) respectively. (B) Shows the excerpt of the enclosed region of the spectrum in (A) with assignment of selected peaks from the nSH2 and cSH2 domains. (C) Quantification of either the peak intensities (for nSH2 residues) or the chemical shift perturbations (for cSH2 residues) of selected peaks from (B). (D) NMR titration of nSH2-cSH2 wt with PLCγ1 pY-peptide (NPGFpYVEANPMP). An overlay of the two-dimensional 1 H-15 N HSQC spectra of 15 N-labelled nSH2-cSH2 wt are shown in purple, blue, cyan, green, yellow, orange and red at 0, 0.2, 0.7, 1.0, 1.8, 2.1 and 3.0 equivalents (molar ratio of peptide to protein) respectively. (E) Shows the excerpt of the enclosed region of the spectrum in (D) with assignment of selected peaks from the nSH2 and cSH2 domains. (F) Quantification of either the peak intensities (for nSH2 residues) or the chemical shift perturbations (for cSH2 residues) of selected peaks from (E).
Figure S6. Further analysis of cSH2 and catalytic domain mutations in COS cells, related to Figure 5
The effect of point mutations on basal and EGF stimulated PLCγ1 activity were measured in COS7 cells transfected with pTriEx4-PLCγ1 wt and constructs containing indicated point mutations in cSH2 domain (A) and catalytic domain (B). For comparison of wild type with D1019K mutation in the catalytic domain, PLC activity measured for a range of expression levels (plasmid concentrations are indicated) is shown (left panel). Western blotting was used to show protein expression (insets). SD is represented by error bars.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Cloning, expression and purification of recombinant proteins
Construction of vectors-Full-length human PLCγ1 was cloned using Gateway technology (Invitrogen) into pDONR207 (Invitrogen) and after sequencing transferred by the LR reaction into a Gateway modified version of pTriEx4 (Novagen). These constructs were used primarily for transfections of COS7, PAE and 293F cells and were expressed with an N-terminal Hisx6 tag followed by an S-tag that was used for protein purification and detection of protein expression in Western blotting respectively. Core constructs of PLCγ1 comprising amino acids 13-1215, ∆488-933, H335A were also cloned with Gateway technology into pTriEx4 (via pDONR207) and used in transfections of 293F suspension cells. In this case an HRV 3c protease recognition sequence was included to allow a native N-terminus (amino acid residue 13) after cleavage. All specific array and smaller constructs were cloned into vector pOPINS (Oxford Protein Production Facility) using In-Fusion technology (Clontech). The exceptions to this were the SH3 domain (791-851, C794S) and spPH domain (488-933, ∆530-864) that were cloned into pTriEx4 using Ek/LIC cloning (Novagen) and incorporated an N-terminal TeV protease recognition sequence.
A synthetic ORF encoding for the human FGFR1 kinase domain (456-774, L457V, Y463F, C488A, Y583F, C584S, Y585F) was prepared by EuroFins MWG. A construct was prepared by splicing PCR consisting of the following elements in order, 2 x StrpII tags, Sumo Star domain, FGFR1 (464-774) and a 10 x His-tag. This construct was cloned into pTriEx6 using 3C/LIC cloning (Novagen). The resulting protein was designated as FGFR1-3p on account of the fact that three tyrosines only can be phosphorylated in this construct (Y653, 654 and 766) The FGFR1opt (456-774) was also cloned into pOPINS using In-Fusion cloning and the active site tyrosines, 653 and 654, were mutated to phenylalanine residues. This protein was designated as FGFR1-1p since only one tyrosine, Y766, can be phosphorylated in this construct.
All constructs for cloning were PCR amplified using KOD Hot Start polymerase (Novagen) following manufacturer's protocols. All PLCγ1 and FGFR1 variants with deletions and point mutations were introduced by site-directed mutagenesis (QuikChange PCR mutagenesis, Stratagene). All clones ORFs were fully sequenced after manipulation to ensure sequence fidelity.
Expression of recombinant proteins -For expression of Specific Array and smaller
domain constructs of PLCγ1 from pTriEx4 or pOPINS vector backbones in rich media. Constructs were transformed into E.coli strain C41 (DE3). Colonies were inoculated into 500 ml of 2xYT media and grown to an OD600 of 0.4. Cultures were cooled to 25 °C for 2 hours and expression was induced with 100 µM IPTG for approximately 16 hours. Bacteria were pelleted and stored at -20 °C until processed.
For expression of FGFR1 containing constructs from the pTriEx6 or pOPINS vector backbones in rich media. Constructs were transformed into E.coli strain C41 (DE3) harbouring a construct expressing λ-phosphatase. Colonies were inoculated into 500 ml of terrific broth and grown to an OD600 of 1.0. Cultures were cooled to 15 °C and expression was induced with 100 µM IPTG for approximately 16 hours. Bacteria were pelleted and stored at -20 °C until processed. °C. Minimal media agar plates were prepared containing the appropriate antibiotic with 3 plates necessary for every 500 ml planned culture. Each plate was spread with 100 µl of the LB culture and bacterial lawns allowed to grow overnight at 37 °C.
Bacteria were scraped from the plates into 500 ml of minimal media containing a The protein/protease mix was dialysed overnight at 4 °C against 500 ml of Dialysis Buffer (25 mM Tris.Cl, 150 mM NaCl, 10 mM Imidazole and 1 mM TCEP, pH 8.0).
Subsequently, proteins were passed again over the 5 ml HisTrap column and material that did not bind was collected. These proteins were dialysed against Low Salt Dialysis Buffer (25 mM Tris.Cl, 20 mM NaCl, 1 mM TCEP, pH 8.0) for a minimum of 3 hours at 4 °C. Subsequently, proteins were further purified by application to a 5 FGFR1 with 2xStrpII tags as expressed from pTriEx6 were purified differently after the HisTrap purification step. Fractions of these proteins were immediately applied to a 5 ml Streptactin column (GE Healthcare) and washed with Streptactin Buffer A (25 mM Tris.Cl, 150 mM NaCl, pH 8.0) to remove non-specifically bound contaminants.
The recombinant proteins were eluted from the column using Streptactin Buffer B (25 mM Tris.Cl, 150 mM NaCl, 5 mM desthiobiotin, pH 8.0). Eluted protein was further purified as above using standard Gel Filtration Buffer, concentrating and storing the protein. found that phosphorylation and subsequent isolation of preparations phosphorylated at all 3 residues or specifically at one or more residues was practically very challenging.
Furthermore, tandem proteins phosphorylated at Y771 or Y775 often form complexes with the SH2 domains form other tandem molecules, leading to aggregation.
Therefore, to simplify the procedure and increase the homogeneity of the preparation, 2 of the tyrosine residues, Y771 and Y775 (shown not to be important for activation of PLCγ1), were mutated to phenylalanine. This mutant tandem, nSH2-cSH2 Y771F,Y775F was shown to behave identically to the wild-type in pull-down assays.
Nevertheless, a method could still not be designed to allow separation of the nonphosphorylated from the pY783-phosphorylated tandem. Instead the following method was applied to maximize the amount of pY783 tandem produced, which relies on the discovery that pY783 tandem (as well as phosphorylated γ1SA and full-length PLCγ1) has a lower affinity for FGFR1 than the non-phosphorylated variants. 
Phosphorylation of PLCγ1 full length (Y186F, Y472F, Y481F, Y771F, Y775F, Y959F, Y977F, Y1254F) for SAXS measurements-Although the wt variant of full length
PLCγ1 could be phosphorylated in vitro with FGFR1, the resulting protein was prone to aggregation at high concentrations and could not be used in SAXS measurements.
To overcome this hurdle, we mutated all the tyrosine phosphorylation sites except Y783 to phenylalanine. The resulting mutant protein was phosphorylated in a manner identical to that outlined above for the tandem mutant except that 15 mg of PLC was used.
Crystallography, NMR and SAXS measurements
Crystallography-Crystals of both apo and phosphorylated (nSH2-cSH2) were prepared by the hanging drop vapor diffusion method. The apo form of the protein was crystallized using 22% PEG 5000 MME, 0.1M Na Malonate and 20mM CaCl 2 as a precipitant and the phosphorylated form crystallized in 18 % PEG 8000, 0.1 M HEPES.Na and 200 mM Calcium Acetate, pH 7.5. The protein concentration used was 10 mg/ml for both crystal forms and plates were incubated at 16°C. The crystals were cryoprotected using 30% ethylene glycol made up in the precipitant solution then added in an equal volume to drops followed by transfer of crystals into the cryosolution prior to flash freezing. Data were collected for the apo form at ID29 at the ESRF and for the phosphorylated form at IO4 at the DIAMOND Synchrotron.
The data was processed using the XDS package for integration of the images, the CCP4 package for further processing and the BUSTER package for refinement.
Building was carried out with the program COOT. Final images were created using the program PYMOL.
Nuclear Magnetic Resonance-NMR experiments of labeled protein constructs were typically executed in a protein construct concentration range of 0.2-0.5 mM. The titration experiments with unlabeled partner (0-3.0 molar equivalents) were conducted at constant concentration of the labeled component (McAlister et al, 1996) . Typical acquisition times for 2D WATERGATE-flipback 15 N, 1 H-HSQC (Grzesiek & Bax, 1993) datasets were ~1 h.
15
N Relaxation Measurements-Spin relaxation data were collected at 25° C for a 200 mM 15 N-labeled tandem nSH2-cSH2 construct (residues 545-790) on a Bruker AVANCE spectrometer operating at 600MHz. R1 and R2 were collected as previously described (Kay et al, 1989) . R1 and R2 values were determined for each residue by fitting an exponential decay to the peak intensity of data collected in an interleaved manner to minimize time dependent temperature or stability effects with delay times in random sequence. T1 longitudinal recovery delays were set to 10, 100, 200, 300, 500, 800, 1000 and 1500 ms. T2 transverse recovery delays were set to 8, 24, 48, 72, 96, 128, 160 and 208 ms. In each case the error was determined from the fit according to a procedure implemented in CCPN Analysis (Vranken et al, 2005 ).
Residues were excluded in which overlap in the data precluded accurate measurement of peak intensity. Isotropic correlation times were determined using the programe TENSOR2 (Dosset et al, 2000) . Data for residues where R2/R1 deviated significantly from the bulk, indicative of local motion or chemical exchange, were also excluded from the fits.
Differential line broadening analysis-The trajectory of the cross-peak intensities (inversely related to the contributing linewidths) in multidimensional heteronuclear
NMR spectra employed to monitor interactions between macromolecules can reflect contributions from fast, intermediate and slow exchange. For a given cross peak the outcome will depend upon the 'local' magnitudes of the chemical shift difference (s) between the species in solution (including any intermediates along the reaction pathway) and the relevant microscopic rate constants. Wagner and co-workers (Matsuo et al, 1999) recognised that it is useful to profile the effect upon cross-peak linewidths and intensities by measurement of the quantity
where h 0,i and h i represent the individual cross peak heights from the labeled protein spectrum in the absence and presence of a specific concentration of the binding partner, and H 0 and H i represent the average peak heights in the corresponding 2D
NMR spectrum . A non-uniform profile of the quantity Δ i ( Figure   5B in the main manuscript) across the polypeptide chain would indicate differential line broadening in the binding reaction potentially highlighting regions of the labelled protein that are most strongly perturbed in the encounter with the binding partner.
SAXS data collection and analysis-Synchrotron SAXS data were collected on the EMBL X33 camera with a Pilatus detector on the storage ring DORIS III (Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany) and ESRF ID14-3 camera with a Pilatus detector (ESRF, Grenoble, France). All samples were measured for at least three solute concentrations ranging from 1 mg/ml to 1-10 mg/ml. The data were processed by the program PRIMUS (Konarev et al, 2003) following standard procedures (Svergun & Koch, 2002) to compute the radii of gyration (Rg) and maximum dimensions (Dmax). The distance distribution functions, p(r), were evaluated using the program GNOM (Svergun, 1992) . The molecular masses of the solutes were estimated by calibration against reference solutions of bovine serum albumin. The excluded particle volumes Vp were computed from the scattering data using Porod invariant (Porod, 1982) .
Low resolution models of PLCγ fragments were generated by the ab initio program DAMMIN (Svergun, 1999) , which represents a protein by volume filled with the packed spheres referred to as dummy atoms. The results of 10 independent DAMMIN runs were analyzed and averaged by SUPCOMB (Kozin & Svergun, 2001 ) and DAMAVER .
Multiple fitting and pairwise comparison of SAXS data for different constructs have been determined by ab initio program MONSA (Svergun, 1999) which is an extended version of DAMMIN for multiphase bead modeling and allows to fit simultaneously multiple curves. MONSA reads in multiple data sets and information about the presence or absence of components in the construct.
XPLOR-NIH Protocol to generate random structures for EOM-
The SH3 (residues 791-852, PDB 1HSQ), splitPH (residues 488-521 and 874-933, PDB 2FLJ) and tandem nSH2-cSH2 domains (residues 549-767, crystal structure) were treated as rigid bodies. The tandem SH2 structure was held fixed in space whilst the linker regions were given Cartesian degree of freedom. The generation of the structures comprised 4 steps.
Step 1. The relative positions and rotations of the globular domains were randomized, breaking the bonds between the linking segments and the domains (residue pairs 521/522, 548/549, 767/768, 790/791, 852/853, 873/874) . Backbone torsion angles in the linker regions were also randomized.
Step 2. The highly distorted bonds linking the randomized linker regions and the globular domains were reconstructed . The geometry of the linker regions was then optimized, allowing the domains to rotate and translate as rigid bodies and with full Cartesian degree of freedom for the linker regions, by 3 cycles of minimization (1000 steps each) to optimize the bond, angles and improper terms.
Step 3. A final gradient minimization was performed with potential energy terms that include bonds, angles, improper torsions, van der Waals and Ramachandran database potential terms allowing the splitPH and SH3 domains to move relative to the tandem nSH2-cSH2 as rigid bodies.
Step 4. Simulated annealing with temperature from 3000 to 25 K is performed with steps of 25K. The dynamics runs for 800 ps or 8000 variable time steps (whichever ends first) and includes all the potentials.
For the restrained model pool, highly ambiguous inter-residue distance restraints were created corresponding to the perturbed resonances in the splitPH and cSH2 domains according to a procedure described by Clore et al. (Clore & Schwieters, 2003) . The distance restraints were applied using a soft asymptotic square-well energy function with restraints distances calculated as sum-averages over all relevant atom selection pairs, following the randomization of the relative domains positions and prior to reforming the peptide bonds with the linker segments. Full Cartesian degree of freedom was given to the side chains of the residues undergoing chemical shift perturbation.
For clarity, the XPLOR-NIH SAXS and ratio of gyration potential energy terms were not used in the generation of the unrestrained and restrained EOM model pools.
XPLOR-NIH Protocol to generate docked starting structure for ensemble refinement-
In addition to the EOM approach we separately attempted to exploit the ensemble modelling approaches to fitting SAXS data provided within the advanced features of the XPLOR-NIH v2.27 software package. Thus instead of using a genetic algorithm to filter a pre-generated pool of conformations for sets that together provide a good fit to the SAXS data, the dynamical simulated annealing target function of XPLOR-NIH can be made to include the experimental SAXS scattering data as part of the target function (along with other experimental restraints) whilst simultaneously requiring the target function to be fit for an ensemble of multiple structural models.
The procedure to generate the starting structures for the XPLOR-NIH ensemble refinement was very similar to the approach adopted for the early stage of the EOM approach (see above). Thus, starting from a hand-built model of the SA structure, the bonds between the globular domains and linking segments were broken, the linker backbone torsion angles randomized, and the bonds reformed under the influence of the SAXS and NOE (see below) potential with a procedure similar to that adopted by Schwieters et al. (Schwieters et al, 2010) .
A simulated annealing procedure including all the potentials (including that for backbone torsion angles) was performed similarly to the generation of the random SA structures for EOM.
The docking procedure was repeated five times and the output structures were scored on the basis of their SAXS and NOE energies. Of these the best model was selected for further calculations. Overall a total of 200 conformers were generated for analysis
and subsequent ensemble refinement.
Similarly to the EOM method we model transient interactions between the cSH2 and spPH domains using highly ambiguous NOE restraints involving all the backbone and side chain atoms of the residues that display chemical shift perturbations in the NMR spectra (as above). (RAP) potential terms were not used. The use of Rg potential would constrain each member of the ensemble to have the same radius of gyration whilst the RAP potential is used to keep the ensemble members from drifting too far apart.) Full torsional freedom was given to the linkers (that reduces the convergence but increases the probability that the ensemble members will have different domain arrangements).
XPLOR-NIH Ensemble refinement-
At the end of the calculation the 25 four-member ensembles that best agree with the experimental SAXS data were selected for structural analysis (a total of 100 structural models).
As the number of calculated conformations is large, a weighted atomic probability density map was used to represent the relative domain positions. A volumetric mass density map was calculated corresponding to the atoms of the spPH domain using the program VMD (Humphrey et al, 1996) . The map represents the variation of the position of the spPH domain relative to that of the tandem nSH2-cSH2 domains (which was held fixed during the calculations). The volumetric map was calculated for the residues 488-521 and 874-933 over a 3Å resolution grid with an effective atomic size taken corresponding to three times the corresponding standard atomic radius. The volumetric map was weighted according to the atomic masses to obtain the overall mass distribution and represented as a wireframe isosurface. Pull Down experiments-The pull down assay was used to immobilize FGFR1-3p
Functional Assays
Analysis of inositol phosphate formation in intact COS-7 and PAE cells-COS-
proteins and pull down PLCγ1 constructs (full length or γSA). To bind 2xStrpII-tagged FGFR1-3p to Streptactin Macroprep beads (IBA), 57 µg of FGFR1-3p was immobilized on 300 µl of Streptactin Macroprep beads in Pull Down Buffer (PDB) (50 mM Tris.Cl, 150 mM NaCl, 25 mM MgCl 2 , 1 mM MnCl 2 , 2 mM TCEP, 0.1 % (v/v) Triton-X-100, pH 8.0) to which 10 mM ATP had been added. Incubation was carried out at room temperature for 1 hour with constant agitation. The beads were subsequently washed five times in 500 µl of PDB to remove ATP and any unbound protein and then resuspended in 1.1 ml of PDB. The PLCγ1 molecules were diluted to 0.3 mg/ml (Full length) or 0.6 mg/ml (γSA). Subsequently, to each microfuge tube the following were added, 100 µl of FGFR1-3p loaded beads, 500 µl of PDB containing either 10 mM ATP or not, 50 µl of the PLCγ1 construct and incubated at room temperature for 1 hour with constant agitation. The beads were then washed five times in PDB and then were boiled in 50 µl Laemmli buffer and a 20 µl aliquot subjected to SDS-PAGE. Gels were stained with Colloidal Coomassie and imaged with a Syngene G-Box gel documentation system. Bands were quantified using ImageJ software.
In-vitro PLC assay-Experiments to determine the effect of phosphorylation or the removal of the regulatory γSA on PLC activity used phospholipid vesicles containing 33 mM PtdIns(4,5)P 2 , 536 µM PE, and ~15,000 cpm/assay Mass Spectrometry analysis of peptides-Proteins were digested directly in excised fragments from SDS-PAGE gels using trypsin or other proteases. Samples were infused into an LTQ Velos Orbitrap mass spectrometer (Thermo Fisher Scientific, Hemel Hempstead, UK). MS/MS were acquired using data dependent acquisition to sequence the top 10 most intense ions using enhanced ion trap scans. Raw MS/MS data was submitted for database searching using Proteome Discoverer v1.2 and Mascot v2.2. MS/MS-based peptide and protein identifications were grouped and validated using Scaffold v3.0 (Proteome Software Inc., Portland, OR). For characterization of phosphorylation sites the spectra visually inspected to evaluate the accuracy in localisation of the assigned modification(s).
